| 1 |
28039317 | Subcutaneous interferon β-1a in the treatment of clinically isolated syndromes: 3-year and 5-year results of the phase III dosing frequency-blind multicentre REFLEXION study. | 2017 Apr |
1 |
| 2 |
26991559 | The effect of inflammation and its reduction on brain plasticity in multiple sclerosis: MRI evidence. | 2016 Jul |
1 |
| 3 |
24336144 | Assessing treatment response to interferon-β: is there a role for MRI? | 2014 Jan 21 |
1 |
| 4 |
23378325 | Predictors of long-term outcome in multiple sclerosis patients treated with interferon β. | 2013 Jan |
2 |
| 5 |
22492130 | Intramuscular interferon beta-1a is effective in Japanese patients with relapsing-remitting multiple sclerosis: a pre-treatment versus treatment comparison study of gadolinium-enhanced MRI brain lesions. | 2012 Dec |
1 |
| 6 |
22513956 | Daclizumab for relapsing remitting multiple sclerosis. | 2012 Apr 18 |
1 |
| 7 |
19200860 | Lessons from randomised direct comparative trials. | 2009 Feb 1 |
1 |
| 8 |
19267105 | Disappearance of gadolinium enhancement in a chemoresistant astrocytoma of the tectum after high-dose interferon beta. | 2008 Nov-Dec |
2 |
| 9 |
15651905 | Intramuscular interferon-beta-1a: in patients at high risk of developing clinically definite multiple sclerosis. | 2005 |
1 |
| 10 |
12764062 | Expression profiling identifies responder and non-responder phenotypes to interferon-beta in multiple sclerosis. | 2003 Jun |
1 |
| 11 |
12909305 | Adhesion molecules and matrix metalloproteinases in Multiple Sclerosis: effects induced by Interferon-beta. | 2003 Aug 15 |
1 |
| 12 |
11282166 | T lymphocytes conditioned with Interferon beta induce membrane and soluble VCAM on human brain endothelial cells. | 2001 Apr 2 |
1 |
| 13 |
10802778 | Magnetization transfer ratio in new MS lesions before and during therapy with IFNbeta-1a. | 2000 May 9 |
1 |
| 14 |
11006365 | Intramuscular interferon beta-1a therapy initiated during a first demyelinating event in multiple sclerosis. CHAMPS Study Group. | 2000 Sep 28 |
1 |
| 15 |
11050025 | The effect of interferon beta-1b treatment on MRI measures of cerebral atrophy in secondary progressive multiple sclerosis. European Study Group on Interferon beta-1b in secondary progressive multiple sclerosis. | 2000 Nov |
1 |
| 16 |
9385476 | Rationale for early treatment with interferon beta-1a in relapsing-remitting multiple sclerosis. | 1997 Sep-Oct |
1 |
| 17 |
8602746 | Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG) | 1996 Mar |
2 |